BUX.CN
BioMark Diagnostics Inc
Price:  
0.23 
CAD
Volume:  
4,500.00
Canada | N/A
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BUX.CN Relative Valuation

-106.8%
Upside

As of 2024-05-27, the Relative Valuation of BioMark Diagnostics Inc (BUX.CN) is (0.02) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.23 CAD, the upside of BioMark Diagnostics Inc based on Relative Valuation is -106.8%.

The range of the Relative Valuation is (0.01) - (0.11) CAD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 0.7x - 6.9x 0.9x
Forward P/E multiples -1.9x - 6.5x 0.9x
Fair Price (0.01) - (0.11) (0.02)
Upside -105.4% - -148.7% -106.8%
0.23 CAD
Stock Price
(0.02) CAD
Fair Price

BUX.CN Relative Valuation - Historical P/E Data

Date P/E
2024-05-24 -13.30
2024-05-23 -13.30
2024-05-22 -14.78
2024-05-21 -14.19
2024-05-17 -14.19
2024-05-16 -16.55
2024-05-15 -15.96
2024-05-14 -16.55
2024-05-13 -16.55
2024-05-10 -14.48
2024-05-07 -16.55
2024-05-06 -15.96
2024-05-03 -16.55
2024-05-02 -16.55
2024-05-01 -16.55
2024-04-30 -16.85
2024-04-29 -17.14
2024-04-26 -17.73
2024-04-25 -18.03
2024-04-24 -17.73
2024-04-23 -18.62
2024-04-22 -17.14
2024-04-19 -17.73
2024-04-18 -17.14
2024-04-17 -16.55
2024-04-16 -16.55
2024-04-15 -17.44
2024-04-11 -17.73
2024-04-10 -17.73
2024-04-09 -18.32
2024-04-08 -17.73
2024-04-05 -17.73
2024-04-03 -17.73
2024-03-28 -17.73
2024-03-27 -17.73
2024-03-26 -17.73
2024-03-25 -18.32
2024-03-21 -18.32
2024-03-18 -18.62
2024-03-15 -18.32
2024-03-13 -18.32
2024-03-11 -18.03
2024-03-08 -17.73
2024-03-07 -17.73
2024-03-06 -17.73
2024-03-05 -18.03
2024-03-04 -17.73
2024-02-29 -17.73
2024-02-28 -18.03